학술논문
Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial
Document Type
Article
Author
Kintu, Kenneth; Malaba, Thokozile R; Nakibuka, Jesca; Papamichael, Christiana; Colbers, Angela; Byrne, Kelly; Seden, Kay; Hodel, Eva Maria; Chen, Tao; Twimukye, Adelline; Byamugisha, Josaphat; Reynolds, Helen; Watson, Victoria; Burger, David; Wang, Duolao; Waitt, Catriona; Taegtmeyer, Miriam; Orrell, Catherine; Lamorde, Mohammed; Myer, Landon; Khoo, Saye
Source
In The Lancet HIV May 2020 7(5):e332-e339
Subject
Language
ISSN
2352-3018